Autumn Glory Partners LLC Sells 30,700 Shares of Sabra Healthcare REIT, Inc. $SBRA

Autumn Glory Partners LLC lessened its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 67.3% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,900 shares of the real estate investment trust’s stock after selling 30,700 shares during the period. Autumn Glory Partners LLC’s holdings in Sabra Healthcare REIT were worth $275,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp lifted its holdings in shares of Sabra Healthcare REIT by 1.8% in the first quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust’s stock valued at $71,875,000 after purchasing an additional 74,564 shares in the last quarter. Nuveen LLC bought a new position in Sabra Healthcare REIT during the 1st quarter valued at approximately $61,791,000. Advisors Capital Management LLC grew its stake in shares of Sabra Healthcare REIT by 20.5% in the 1st quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust’s stock worth $39,004,000 after buying an additional 380,505 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Sabra Healthcare REIT by 16.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,687,977 shares of the real estate investment trust’s stock worth $29,489,000 after purchasing an additional 243,274 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its position in Sabra Healthcare REIT by 12.7% during the first quarter. Victory Capital Management Inc. now owns 1,630,076 shares of the real estate investment trust’s stock valued at $28,477,000 after purchasing an additional 183,739 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

Shares of NASDAQ:SBRA opened at $18.14 on Monday. The firm’s 50 day simple moving average is $18.77 and its 200 day simple moving average is $18.16. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The company has a market capitalization of $4.35 billion, a price-to-earnings ratio of 23.87, a P/E/G ratio of 1.45 and a beta of 0.85.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.02. The business had revenue of $189.15 million during the quarter, compared to analysts’ expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.Sabra Healthcare REIT’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.6%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 157.89%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on SBRA shares. Truist Financial boosted their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research note on Tuesday, September 2nd. Wells Fargo & Company raised their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Wednesday, August 27th. Cantor Fitzgerald began coverage on shares of Sabra Healthcare REIT in a report on Wednesday. They set a “neutral” rating and a $20.00 price target for the company. BMO Capital Markets lifted their price objective on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research report on Monday, August 25th. Finally, Scotiabank boosted their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research note on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $20.71.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.